National Comprehensive Cancer Network
- NCCN
Guidelines®- End User License Agreement
- NCCN Guidelines for
Treatment of Cancer by Site- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
- Anal Carcinoma
- Basal and Squamous Cell Skin Cancers
- Bladder Cancer
- Bone Cancer
- Breast Cancer
- Central Nervous System Cancers
- Cervical Cancer
- Chronic Myelogenous Leukemia
- Colon Cancer
- Dermatofibrosarcoma Protuberans
- Esophageal and Esophagogastric Junction Cancers
- Gastric Cancer
- NCCN Guidelines for Detection,
Prevention, & Risk Reduction - NCCN Guidelines for
Supportive Care - NCCN Guidelines for
Age Related Recommendations - NCCN Guidelines for Patients®
- International Adaptations & Translations
- NCCN Pocket Guidelines
- NCCN Disclosure Policies &
Potential Conflicts of Interest - Licensing and Permissions
- Stay up-to-date with
NCCN Flash Updates™ - NCCN Guidelines Apps
- NCCN
Compendia- End User License Agreement
- NCCN Compendium®
- NCCN Biomarkers Compendium™
- Subscribe to the NCCN Compendia
- Licensing and Permissions
- Subscriptions
& Products- NCCN Compendium
- NCCN Biomarkers Compendium
- NCCN Templates
- Combination Subscriptions
- NCCN Flash Updates™
- NCCN Flash Updates™ Coupons
- NCCN Trends™ Surveys & Data
- NCCN Academy Video Modules
- NCCN eBulletin Newsletter
- NCCN Health Information Technology Licensees
- JNCCN — Journal of the National Comprehensive Cancer Network
- Advertising Opportunities
- NCCN Online Catalog
- Clinical & Business
Resources- Members Only
- NCCN Corporate Council
- NCCN Academy
- NCCN Insights: Analytics, Research & Consulting
- NCCN Resource Tool: REMS
- NCCN Collaboration with the National Business Group on Health
- NCCN Virtual Reimbursement Resource Room
- NCCN Health Information Technology Licensees
- NCCN Oncology Policy Program White Papers
- NCCN Oncology Research Program (ORP)
- ORP Recent News
- NCCN ORP Affiliate Research Project
- ORP Scientific Publications
- ORP Investigator Steering Committee
- ORP Testimonials
- Clinical Trials at NCCN Member Institutions
- Find ORP Funded Clinical Trials at NCCN Member Institutions
- NCCN Specialized Imaging Research Consortium™ (SIRC)
- NCCN ORP Disclosure Policy
- NCCN ORP for Industry
- NCCN Informed Consent Language Database
- NCCN Content Policies
- Patient
Resources- NCCN Guidelines for Patients®
- NCCN Website for Patients and
Caregivers - NCCN.com - Find an NCCN Member Institution
- Find an NCCN Cancer Center Near You
- Information on Patient Assistance & Reimbursement Help
- NCCN Virtual Reimbursement Resource Room Guide
- Find Clinical Trials
- NCCN Foundation
- Donate to the NCCN Foundation
About NCCN
Palliative Care Panel - Disclosures as of 6/19/2013
View NCCN Management Team Disclosures | View NCCN Guidelines Staff Disclosures | View NCCN ORP Staff Disclosures| Panel Member | Clinical Research Support | Advisory Boards, Speakers Bureau, Expert Witness, or Consultant | Patent, Equity, or Royalty | Other | Date Completed |
|---|---|---|---|---|---|
Amy Alvarez-Perez, MD |
None |
None |
None |
None |
5/17/2013 |
Anthony Back, MD |
None |
None |
None |
None |
1/22/2013 |
Justin N. Baker, MD, FAAHPM |
None |
None |
None |
None |
9/7/2012 |
Mary Anne Bergman |
None |
None |
None |
None |
9/11/2012 |
Susan Block, MD |
None |
None |
None |
None |
5/10/2013 |
Shirley N. Codada, MD |
None |
None |
None |
None |
8/31/2012 |
Shalini Dalal, MD |
None |
None |
None |
None |
9/7/2012 |
Maria Dans, MD |
None |
None |
None |
None |
9/4/2012 |
Deborah Freedman-Cass, PhD |
None |
None |
None |
None |
3/7/2013 |
Kristina M. Gregory, RN, MSN, OCN |
None |
None |
None |
None |
10/23/2012 |
Elizabeth Kvale, MD |
None |
None |
None |
None |
2/21/2012 |
Michael H. Levy, MD, PhD |
None |
Cephalon, Inc. |
None |
None |
4/30/2013 |
Joan S. McClure, MS |
None |
None |
None |
None |
7/23/2012 |
Sumathi Misra, MD |
None |
None |
None |
None |
9/5/2012 |
Todd M. Sauer, MD |
None |
None |
None |
None |
8/16/2012 |
Thomas Smith, MD |
Competitive Technologies (makers of Scrambler therapy); |
Competitive Technologies (makers of Scrambler therapy); |
None |
none |
10/8/2012 |
David Spiegel, MD |
National Cancer Institute; |
None |
None |
None |
8/17/2012 |
Linda Sutton, MD |
GW Pharma |
None |
None |
None |
11/16/2012 |
Robert M. Taylor, MD |
None |
None |
None |
None |
5/9/2012 |
Jennifer Temel, MD |
None |
None |
None |
None |
8/18/2012 |
Roma Tickoo, MD, MPH |
None |
None |
None |
None |
9/3/2012 |
Susan G. Urba, MD |
Eisai Inc. |
Amgen Inc. |
None |
None |
6/20/2012 |
Carin Van Zyl, MD |
None |
None |
None |
None |
3/29/2013 |
Jamie H. Von Roenn, MD |
None |
AstraZeneca Pharmaceuticals LP |
None |
Archimedes |
9/24/2012 |
Sharon M. Weinstein, MD, FAAHPM |
None |
None |
None |
None |
1/18/2012 |
About NCCN| NCCN Member Institutions| Patient Resources| NCCN Foundation| Privacy Policy| Legal Notices| Contact Us
275 Commerce Drive, Suite 300, Fort Washington, PA 19034 • 215.690.0300 • Fax: 215.690.0260
Copyright © 2012 National Comprehensive Cancer Network, All Rights Reserved